Cambodia and Laos Pharmaceuticals and Healthcare Report Q3 2013:Life Sciences Market Research Reports

Life Sciences Market Research Reports

Cambodia and Laos Pharmaceuticals and Healthcare Report Q3 2013 Jun 26th 2013, 00:00 BMI View: We maintain that significant foreign interest in Cambodia will be unlikely given the lack of proper regulation, rampant corruption and poor infrastructure in the country. In addition, due to low per capita pharmaceutical and healthcare expenditure, the market will only be attractive to producers of low-value pharmaceutical products such as generic drugs and over-the-counter drugs from other countries, such as Vietnam. Headline Expenditure Projections ? Pharmaceuticals: KHR721.1bn (US$170mn) in 2012 to KHR790.9bn (US$190mn) in 2013; +9.7% in local currency terms and +8.2% in US dollar terms. Forecast broadly in line with Q213. ? Healthcare: KHR3,167.1bn (US$760mn) in 2012 … Order / Buy a copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=104072. Complete report details with Table of Contents and more @ http://www.rnrmarketresearch.com/cambodia-and-laos-pharmaceuticals-and-healthcare-report-q3-2013-market-report.html.

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions